1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Petosemtamab: new trials by email Literature Review of Petosemtamab trials Research Report on Petosemtamab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors MCLA-158, MCLA-158 + Pembrolizumab, MCLA-158 + FOLFIRI - Advanced/Metastatic Solid Tumors, Colorectal Cancer | Phase 1 / Phase 2 | Recruiting | Genmab | 560 | 2018-05-02 | 2026-11-02 |
Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Stomach Neoplasms (1)
Genmab (1)
Belgium (1) · France (1) · Italy (1) · Netherlands (1) · Spain (1) · United Kingdom (1) · United States (1)
2017 (1)